TR128 capsule, a new drug for the treatment of advanced malignant solid tumors, has been approved by the National Medical Products Administration for clinical trials.
Dec 1, 2022
0
3
Pancreatic islets are mini-organs that make and release insulin and several other peptide hormones to control our glucose levels. Although various studies have previously looked at how pancreatic cells communicate with each ...
Nov 28, 2022
0
37
Tumor cells in the most common pancreatic cancer share nutrients to live and grow. A new discovery by University of California, Irvine biologists and collaborators during a four-year investigation could help lead to better ...
Nov 22, 2022
0
63
Researchers from Barts Cancer Institute at Queen Mary University of London have identified a new channel of communication through which non-cancerous cells drive the invasion of cancer cells in pancreatic cancer.
Nov 10, 2022
0
116
According to a study, type 1 diabetes could be prevented by inhibiting a gene associated with the onset of the disease. A drug based on the same mechanism has already been approved for the treatment of another autoimmune ...
Nov 9, 2022
0
71
Scientists have used a transplant procedure to apparently cure diabetes in lab mice, without the need for immune-suppressing drugs afterward.
Nov 8, 2022
0
26
Researchers led by Osaka University have now identified a mechanism by which a lack of insulin may be reported back to the pancreatic cells that produce insulin, identifying a potential new therapeutic target for diabetes.
Nov 7, 2022
0
4
Research led by Pamela-Itkin-Ansari, Ph.D., and Randal Kaufman Ph.D., has mapped out a network of biochemical interactions that help special cells in the pancreas called islet cells create insulin, shedding light on the origins ...
Oct 27, 2022
0
25
A new approach to cancer immunotherapy that uses one type of immune cell to kill another—rather than directly attacking the cancer—provokes a robust anti-tumor immune response that shrinks ovarian, lung, and pancreatic ...
Oct 25, 2022
0
89
Investigators have designed an antibody-based treatment that eliminated circulating tumor cells (CTCs) in mouse models of breast and pancreatic cancer. The research, which was led by scientists at Massachusetts General Hospital ...
Oct 20, 2022
0
50
